Mainz Biomed N.V. Profit Margin

The latest profit margin for MYNZ is -4158.43% as of June 2026. That compares with -2637.62% in the prior-year period — down 57.7% year over year. That is below the sector sector average of 21.59%. Investors often review this figure alongside Mainz Biomed N.V.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, MYNZ's profit margin moved from -2637.62% to -4158.43% — a 57.7% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Mainz Biomed N.V.'s valuation or profitability profile.

Against its sector companies, MYNZ currently prints -4158.43% for profit margin, while the sector average sits near 21.59%. That is roughly 19358.8% below the sector mean. Large gaps often invite a closer look at Mainz Biomed N.V.'s growth, margins, and balance sheet.

Profit Margin shows how effectively Mainz Biomed N.V. converts resources into returns. At -4158.43%, MYNZ may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -2637.62% in the prior-year period — down 57.7% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting MYNZ's profit margin (-4158.43%), review year-over-year change from -2637.62%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.